Heng Luo

Dr. Heng Luo


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2017 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
LFLi-Li Fang
Li-Li Fang
XWXing-Hui Wang
Xing-Hui Wang
BSBao-Fei Sun
Bao-Fei Sun
XZXiao-Dong Zhang
Xiao-Dong Zhang
XZXu-Hui Zhu
Xu-Hui Zhu
HLHeng Luo
Heng Luo
MicroRNAs (miRNAs), a class of short, single‑stranded non‑coding RNAs, regulate and control gene expression in eukaryotes by degrading mRNA at the post‑transcriptional level. Regulation by miRNAs involves a plethora of biological processes, such as cell differentiation, proliferation, metastasis, metabolism, apoptosis, tumorigenesis and others. miRNAs also represent a powerful tool in disease diagnosis and prognosis. The miR‑17‑92 cluster, one of the most extensively investigated microRNA clusters, comprises six mature miRNA members, including miR‑17, miR‑18a, miR‑19a, miR‑19b, miR‑20a and miR‑92a. Originally identified as being involved in tumorigenesis, it is currently evident that the expression of the miR‑17‑92 cluster is upregulated in a wide range of tumor cells and cancer types; thus, this cluster has been identified as a potential oncogene. Considering the growing interest in the field of miR‑17‑92 research, we herein review recent advances in the expression and regulation of this cluster in various cancer cells, discuss the proposed mechanism of action for tumorigenesis and tumor development, and propose clinical and therapeutic applications for miR‑17‑92 cluster members, such as potential cancer biomarkers.

1 June 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
LXLei Xia
Lei Xia
YXYu-Fen Xia
Yu-Fen Xia
LHLi-Rong Huang
Li-Rong Huang
XXXiao Xiao
Xiao Xiao
HLHua-Yong Lou
Hua-Yong Lou
HLHeng Luo
Heng Luo

19 May 2020 in Aging
Verified
Journal Article
Open access
YZYongqiang Zhang
Yongqiang Zhang
JYJue Yang
Jue Yang
ZWZhonghang Wen
Zhonghang Wen
XCXiaoyue Chen
Xiaoyue Chen
JYJia Yu
Jia Yu
JZJianguo Zhu
Jianguo Zhu
Although androgen deprivation therapy may initially be effective in prostate cancer, the disease can gradually progress to castration-resistant prostate cancer, at which point chemotherapy becomes the major clinical strategy. In this study, we demonstrated the anti-cancer potential of a novel 3',5'-diprenylated chalcone (C10), which selectively inhibited the proliferation of PC3 cells in vitro and in vivo. C10 treatment elevated the proportion of PC3 cells in sub-G1 phase and induced programmed cell death. Interestingly, C10 elicited concurrent Caspase-dependent apoptotic and gasdermin E-dependent pyroptotic events. RNA-Seq and bioinformatics analyses revealed a strong correlation between protein kinase C delta (PKCδ) and mitogen-activated protein kinase pathway activation in prostate cancer. PKCδ silencing in PC3 cells suppressed the activation of the JNK pathway and the expression of its downstream genes, including Bax, interleukin-6 and interleukin-1β, which are involved in apoptotic and pyroptotic processes. Moreover, in PC3 cell xenograft tumor tissues, C10 treatment inhibited tumor growth and upregulated PKCδ. These findings suggest that C10 treatment induces the PKCδ/JNK pathway, thereby activating Caspase-3 and inducing the cleavage of PARP and gasdermin E to execute apoptosis and cell-lytic pyroptosis in prostate cancer cells.

29 February 2016 in Journal of Natural Products
Verified
Journal Article
Closed access
LHLi-Rong Huang
Li-Rong Huang
XHXiao-Jiang Hao
Xiao-Jiang Hao
QLQi-Ji Li
Qi-Ji Li
DWDao-Ping Wang
Dao-Ping Wang
JZJian-Xin Zhang
Jian-Xin Zhang
XYXiaosheng Yang
Xiaosheng Yang

25 July 2023 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
YSYandi Sun
Yandi Sun
QHQian He
Qian He
JLJingjia Li
Jingjia Li
ZYZe Yang
Ze Yang
MAMashaal Ahmad
Mashaal Ahmad
YLYan Luo
Yan Luo
Lactic acidosis is a feature of solid tumors and plays fundamental role(s) rendering cancer cells to adapt to diverse metabolic stresses, but the mechanism underlying its roles in redox homeostasis remains elusive. Here we show that G6PD is phosphorylated at tyrosine 249/322 by the SRC through the formation of a GSTP1-G6PD-SRC complex. Lactic acid attenuates this formation and the phosphorylation of G6PD by non-covalently binding with GSTP1. Furthermore, lactic acid increases the activity of G6PD and facilitates the PPP (NADPH production) through its sensor GSTP1, thereby exhibiting resistance to reactive oxygen species when glucose is scarce. Abrogating a GSTP1-mediated lactic acid signaling showed attenuated tumor growth and reduced resistance to ROS in breast cancer cells. Importantly, positive correlations between immuno-enriched SRC protein and G6PD Y249/322 phosphorylation specifically manifest in ER/PR positive or HER negative types of breast cancer. Taken together, these results suggest that GSTP1 plays a key role in tumor development by functioning as a novel lactate sensor.

1 October 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
YZYong-Qiang Zhang
Yong-Qiang Zhang
ZWZhong-Hang Wen
Zhong-Hang Wen
KWKe Wan
Ke Wan
DYDongbo Yuan
Dongbo Yuan
XZXiaoping Zeng
Xiaoping Zeng
HLHeng Luo
Heng Luo